Cannabis Growth Opportunity Corporation is Pleased to Report that Vireo Commenced Trading on the CSE Under the Symbol "VREO"
Cannabis Growth Opportunity Corporation is Pleased to Report that Vireo Commenced Trading on the CSE Under the Symbol "VREO" |
[26-March-2019] |
TORONTO, March 26, 2019 /PRNewswire/ - Cannabis Growth Opportunity Corporation ("CGOC", or the "Company") (CSE: CGOC), a cannabis focused investment corporation with both public and private cannabis holdings, is pleased to report that Vireo Health International Inc. ("Vireo"), one of the private portfolio holdings commenced trading on the Canadian Securities Exchange ("CSE"), under the symbol "VREO", on March 20, 2019, at an opening price of $5.65. In conjunction with its previously announced business combination with Darien Business Development Corp, Vireo raised over US$50 million by way of brokered and non-brokered private placement offerings. Vireo is a physician-founded and scientifically-focused multi-state medical cannabis company. CEO Dr. Kyle Kingsley founded the Company in 2014 after winning one of only two vertical licenses issued by the state of Minnesota. The Company has gone on to expand its business across multiple states, focusing its efforts on limited license medical states. Vireo has a successful track record of winning licenses in competitive application processes. Jamie Blundell, President and Chief Operating Officer of CGOC commented, "Vireo has proven to be a committed and dedicated company, who have achieved their goals and objectives as stated. We expect significant upside within the company as they continue to expand their reach across the US. "Our investment in Vireo has provided a return of 188% in nine months and is a great example of how our private investments can quickly add value to CGOC. This will positively impact our NAV when calculated in April. At the current share price, CGOC represents a unique and vastly discounted opportunity to benefit from the continued success within this sector." Dr. Kyle Kingsley, CEO and Founder of Vireo commented, "Our partnership with CGOC has been extremely beneficial, providing not only funding, which helped drive our exponential growth in 2018, but also valuable guidance and expertise as we prepared to go list on the CSE. We look forward to continuing our mutually beneficially relationship." Highlights of Vireo Public Offering:
CGOC Return on Investment About Vireo For more information please visit www.vireohealth.com About CGOC Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. View original content to download multimedia:http://www.prnewswire.com/news-releases/cannabis-growth-opportunity-corporation-is-pleased-to-report-that-vireo-commenced-trading-on-the-cse-under-the-symbol-vreo-300818466.html SOURCE Cannabis Growth Opportunity Corporation | ||
Company Codes: CNSX:CGOC, CNSX:VREO, OTC-PINK:CWWBF |
© 2019 PR Newswire. All Rights Reserved.